Literature DB >> 31030357

Optimizing Stature in Congenital Adrenal Hyperplasia: Challenges and Solutions.

Anju Seth1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31030357     DOI: 10.1007/s12098-019-02961-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  13 in total

Review 1.  Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

Review 2.  Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.

Authors:  Kalpana Muthusamy; Mohamed B Elamin; Galina Smushkin; Mohammad Hassan Murad; Julianna F Lampropulos; Khalid B Elamin; Nisrin O Abu Elnour; Juan F Gallegos-Orozco; Mitra M Fatourechi; Neera Agrwal; Melanie A Lane; Felipe N Albuquerque; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

3.  A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.

Authors:  L Laue; D P Merke; J V Jones; K M Barnes; S Hill; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

4.  Long-term Growth in Congenital Adrenal Hyperplasia.

Authors:  Ankita Maheshwari; Vaman Khadilkar; Priyanka Gangodkar; Anuradha Khadilkar
Journal:  Indian J Pediatr       Date:  2018-08-10       Impact factor: 1.967

5.  Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment.

Authors:  H Meena; Manisha Jana; Vishwajeet Singh; Madhulika Kabra; Vandana Jain
Journal:  Indian J Pediatr       Date:  2019-01-30       Impact factor: 1.967

6.  Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty.

Authors:  Ayla Güven; Ayşe Nurcan Cebeci; Suna Hancili
Journal:  Hormones (Athens)       Date:  2015 Apr-Jun       Impact factor: 2.885

Review 7.  Mechanisms of steroid impairment of growth.

Authors:  Ze'ev Hochberg
Journal:  Horm Res       Date:  2002

8.  Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth.

Authors:  S A Rivkees; J D Crawford
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

9.  Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.

Authors:  Zubin Punthakee; Laurent Legault; Constantin Polychronakos
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

10.  Growth characteristics in children with congenital adrenal hyperplasia.

Authors:  Mashael A Alzanbagi; Asmaa A Milyani; Abdulmoein E Al-Agha
Journal:  Saudi Med J       Date:  2018-07       Impact factor: 1.484

View more
  1 in total

1.  Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors.

Authors:  Mariska A M Schröder; Adina F Turcu; Patrick O'Day; Antonius E van Herwaarden; Paul N Span; Richard J Auchus; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.